Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Topical Application of Temperature-Sensitive Gel Containing Caerin 1.1 and 1.9 Peptides on TC-1 Tumour-Bearing Mice Induced High-Level Immune Response in the Tumour Microenvironment. | Front Oncol | 2021 | 34858827 | PubTator, text mining | PubMed |
| Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice. | Front Oncol | 2021 | 34858810 | PubTator, text mining | PubMed |
| Idiopathic inflammatory myopathies. | Nat Rev Dis Primers | 2021 | 34857780 | PubTator, text mining | PubMed |
| Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study. | Int J Gen Med | 2021 | 34853531 | PubTator, text mining | PubMed |
| Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter? | Cancers (Basel) | 2021 | 34830952 | PubTator, text mining | PubMed |
| The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis. | Int J Mol Sci | 2021 | 34830268 | PubTator, text mining | PubMed |
| Hygiene Hypothesis as the Etiology of Kawasaki Disease: Dysregulation of Early B Cell Development. | Int J Mol Sci | 2021 | 34830213 | PubTator, text mining | PubMed |
| Site-Specific Labeling of Endogenous Proteins Using CoLDR Chemistry. | J Am Chem Soc | 2021 | 34817989 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures. | Front Immunol | 2021 | 34803999 | PubTator, text mining | PubMed |
| Selecting Hub Genes and Predicting Target Genes of microRNAs in Tuberculosis via the Bioinformatics Analysis. | Genet Res (Camb) | 2021 | 34803519 | PubTator, text mining | PubMed |
| A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities. | Blood Res | 2021 | 34776414 | PubTator, text mining | PubMed |
| A Novel Blockchain and Bi-Linear Polynomial-Based QCP-ABE Framework for Privacy and Security over the Complex Cloud Data. | Sensors (Basel) | 2021 | 34770606 | PubTator, text mining | PubMed |
| Causal variants in Maturity Onset Diabetes of the Young (MODY) - A systematic review. | BMC Endocr Disord | 2021 | 34763692 | PubTator, text mining | PubMed |
| Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. | Nat Rev Rheumatol | 2021 | 34716418 | PubTator, text mining | PubMed |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. | Cancer Cell | 2021 | 34715028 | PubTator, text mining | PubMed |
| A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling. | Nat Commun | 2021 | 34707113 | PubTator, text mining | PubMed |
| Alterations of DNA methylation during adipogenesis differentiation of mesenchymal stem cells isolated from adipose tissue of patients with obesity is associated with type 2 diabetes. | Adipocyte | 2021 | 34699309 | PubTator, text mining | PubMed |
| A new paradigm for leprosy diagnosis based on host gene expression. | PLoS Pathog | 2021 | 34695167 | PubTator, text mining | PubMed |
| Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development. | Genes (Basel) | 2021 | 34681039 | PubTator, text mining | PubMed |
| Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance. | Cancers (Basel) | 2021 | 34680275 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=31